Using IT and data analytics tools for life sciences & healthcare research and consulting services offers precision comprehensive coverage, ROI, and a quicker turnaround time for white-label research and recommendations.
SG Analytics (SGA) is one of the healthcare market research and consulting services firms in the U.S. that has been supporting pharmaceuticals, medical devices, and life sciences companies to grow revenue and increase market shares over the last 17 years. Unlike many other research firms, our teams ensure your business data is safe with us. Our growth has been majorly in the custom research and consulting space, followed by opportunity analysis and prioritization, market-entry evaluations, and
Using IT and data analytics, SGA has positioned itself as the best healthcare market research and consulting service provider firm globally. We offer the most relevant data metrics and insights into the niche segments of the healthcare industry. We are flexible in terms of data management and use the Amazon Web Services (AWS) platform or work on the client’s server using a VPN.
Our life sciences & healthcare research team helps clients co-create strategic roadmaps, communicate their plans to the right audience, and offer customized solutions for go-to-market strategy development and optimization
SGA helps you evaluate evidence of the value of a new drug or product for reimbursement and healthcare payers using AI/ML tools for crisp and precise solutions.
Approximately $500 billion worth of M&A deals are waiting to happen. We can help you tap into the right audience, tech due diligence, and healthcare intel and cut down the lag phase from search to ‘go-to-market’.
An amalgamation of strategic and market evaluation and competitive analysis for pharma, devices, diagnostics, and other life sciences and healthcare companies are planning to introduce or optimize sales, marketing, or product development amid market competition and price competition. This includes market entry and No/Go decisions on expansion or opportunities.
We help you evaluate new entrant threats, track the current players and technology, check the pulse and power of the suppliers and buyers, and the availability of substitutes and adjacent market opportunities.
Identification, mapping, and engagement of key opinion leaders (KOL) in healthcare through our in-house panel make us the most preferred partner in the industry.
Identifying customers’ imperatives for better targeting, actionable customer segmentation for efficient marketing and sales team performance, buying behavior, the role of influencers, and decision-making for go-to-market strategy optimization or development in case of new products.
Why SGA
Industry Leaders
SGA thrives by its brand promise Lifes Possible and is recognized among the trusted life sciences & healthcare business consulting & services providers in the U.S.
12+ Languages
Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).
Data-Driven Insights
With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.
End-To-End Solutioning
The in-house KOL capability of more than 700, along with in-house capabilities of primary market research, financial research, data analytics, engineering, IT, and ESG research and consulting, helps to present credible competitive information.
Whitepapers
Emergence of Novel Immune - Mediated Therapies
Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to...
Whitepapers
Future Trends and Technological Advances in Vaccine Treatment and Disease Prevention
The introduction of vaccines for key diseases, such as meningococcal meningitis A, hepatitis E, and malaria, in recent years has helped to reduce mortality...
Whitepapers
Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?
Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...
CASE STUDIES
